407 related articles for article (PubMed ID: 34404266)
21. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports.
Najjar S; Najjar A; Chong DJ; Pramanik BK; Kirsch C; Kuzniecky RI; Pacia SV; Azhar S
J Neuroinflammation; 2020 Aug; 17(1):231. PubMed ID: 32758257
[TBL] [Abstract][Full Text] [Related]
22. Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4.
Conte C
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281186
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and impact of COVID-19 in Parkinson's disease: evidence from a multi-center survey in Tuscany region.
Del Prete E; Francesconi A; Palermo G; Mazzucchi S; Frosini D; Morganti R; Coleschi P; Raglione LM; Vanni P; Ramat S; Novelli A; Napolitano A; Battisti C; Giuntini M; Rossi C; Menichetti C; Ulivelli M; De Franco V; Rossi S; Bonuccelli U; Ceravolo R;
J Neurol; 2021 Apr; 268(4):1179-1187. PubMed ID: 32880722
[TBL] [Abstract][Full Text] [Related]
24. The impact of Parkinson's disease on manifestations and outcomes of Covid-19 patients: A systematic review and meta-analysis.
El-Qushayri AE; Ghozy S; Reda A; Kamel AMA; Abbas AS; Dmytriw AA
Rev Med Virol; 2022 Mar; 32(2):e2278. PubMed ID: 34260773
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
Gemmati D; Bramanti B; Serino ML; Secchiero P; Zauli G; Tisato V
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423094
[TBL] [Abstract][Full Text] [Related]
26. Central Nervous System Targets and Routes for SARS-CoV-2: Current Views and New Hypotheses.
Barrantes FJ
ACS Chem Neurosci; 2020 Sep; 11(18):2793-2803. PubMed ID: 32845609
[TBL] [Abstract][Full Text] [Related]
27. Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor.
Li Y; Zhou W; Yang L; You R
Pharmacol Res; 2020 Jul; 157():104833. PubMed ID: 32302706
[TBL] [Abstract][Full Text] [Related]
28. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.
Montalvan V; Lee J; Bueso T; De Toledo J; Rivas K
Clin Neurol Neurosurg; 2020 Jul; 194():105921. PubMed ID: 32422545
[TBL] [Abstract][Full Text] [Related]
29. Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism.
Leta V; Boura I; van Wamelen DJ; Rodriguez-Violante M; Antonini A; Chaudhuri KR
Int Rev Neurobiol; 2022; 165():63-89. PubMed ID: 36208907
[TBL] [Abstract][Full Text] [Related]
30. [COVID-19 and the central and peripheral nervous system].
Ritschel N; Radbruch H; Herden C; Schneider N; Dittmayer C; Franz J; Thomas C; Silva Boos G; Pagenstecher A; Schulz-Schaeffer W; Stadelmann C; Glatzel M; Heppner FL; Weis J; Sohrabi K; Schänzer A; Németh A; Acker T; ;
Pathologe; 2021 Mar; 42(2):172-182. PubMed ID: 33646363
[TBL] [Abstract][Full Text] [Related]
31. Neurological Complications of COVID-19 and Possible Neuroinvasion Pathways: A Systematic Review.
Orrù G; Conversano C; Malloggi E; Francesconi F; Ciacchini R; Gemignani A
Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32937949
[TBL] [Abstract][Full Text] [Related]
32. Relationship Between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review.
Shojaee A; Vahedian-Azimi A; Faizi F; Rahimi-Bashar F; Shahriary A; Galeh HEG; Nehrir B; Guest PC; Sahebkar A
Adv Exp Med Biol; 2021; 1321():53-68. PubMed ID: 33656713
[TBL] [Abstract][Full Text] [Related]
33. Battery for deep brain stimulation depletion in Parkinson's Disease and dystonia patients - a systematic review.
Przytuła F; Dulski J; Sobstyl M; Sławek J
Neurol Neurochir Pol; 2021; 55(4):346-350. PubMed ID: 34056704
[TBL] [Abstract][Full Text] [Related]
34. Pediatric COVID-19: Systematic review of the literature.
Patel NA
Am J Otolaryngol; 2020; 41(5):102573. PubMed ID: 32531620
[TBL] [Abstract][Full Text] [Related]
35. SARS-COV-2 infection and Parkinson's disease: Possible links and perspectives.
Al-Kuraishy HM; Al-Gareeb AI; Kaushik A; Kujawska M; Ahmed EA; Batiha GE
J Neurosci Res; 2023 Jun; 101(6):952-975. PubMed ID: 36717481
[TBL] [Abstract][Full Text] [Related]
36. COVID-19's Clinical-Pathological Evidence in Relation to Its Repercussion on the Central and Peripheral Nervous System.
Morgado AM; Bezerra ALMS; Felix EBG; Júnior JCS; Pinto NB; Neto MLR; de Aguiar Rocha Martin AL
Adv Exp Med Biol; 2021; 1353():197-215. PubMed ID: 35137375
[TBL] [Abstract][Full Text] [Related]
37. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
Cheng H; Wang Y; Wang GQ
J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
[TBL] [Abstract][Full Text] [Related]
38. Does COVID-19 contribute to development of neurological disease?
Mahalakshmi AM; Ray B; Tuladhar S; Bhat A; Paneyala S; Patteswari D; Sakharkar MK; Hamdan H; Ojcius DM; Bolla SR; Essa MM; Chidambaram SB; Qoronfleh MW
Immun Inflamm Dis; 2021 Mar; 9(1):48-58. PubMed ID: 33332737
[TBL] [Abstract][Full Text] [Related]
39. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome.
Devaux CA; Rolain JM; Raoult D
J Microbiol Immunol Infect; 2020 Jun; 53(3):425-435. PubMed ID: 32414646
[TBL] [Abstract][Full Text] [Related]
40. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.
Albini A; Di Guardo G; Noonan DM; Lombardo M
Intern Emerg Med; 2020 Aug; 15(5):759-766. PubMed ID: 32430651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
